Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stem Of Hope is a regenerative medicine healthcare company and clinic focused on offering stem cell-based and related biologic procedures for pain management, chronic conditions, sports injuries, and cosmetic applications. Its website describes the use of adult stem cells, growth factors, platelets, cytokines, hyaluronic acid, PRP therapy, prolotherapy, umbilical cord blood stem cell therapy, and cord tissue stem cell therapy. The company presents itself as operating clinically from Newport Beach, California while also listing Las Vegas, Nevada contact information and discussing broader laboratory expansion plans. Stem Of Hope appears to be primarily a treatment provider rather than a traditional drug-development biotech with a disclosed therapeutic pipeline. Publicly available information indicates it is an active private corporation in Nevada.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stem Of Hope.